Giles Richard Platford

At a glance: Giles Richard Platford is President at Takeda Pharmaceutical (TAK). Their latest SEC Form 4, filed Nov 5, 2026, reported a sale of $1.2M. On file: 0 purchase lines ($0) and 2 sale lines ($1.7M).

Disclosed holdings: about $5.8M of TAK stock: 270,253 shares reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 13, 2026 close of $21.43. This counts only TAK shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

President at Takeda Pharmaceutical Co Ltd (TAK)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—

Avg. 90-day return—

vs. S&P 500—

Beat the market—

Paper profit on buys$0

Total bought / sold$0 / $1.7M

Reported trades

Filed	Stock	Type	Shares	Price	Value	Since
Nov 5SEC	TAKTakeda Pharmaceutical Co Ltd	Sell	55,617270,253 held (−17%)	$20.90	$1.2M	+2.5%
Aug 12SEC	TAKTakeda Pharmaceutical Co Ltd	Sell	31,083315,838 held (−9%)	$17.10	$532K	+25.3%

Follow Giles Richard Platford

Get one email when Giles Richard Platford files a new purchase or sale. Free.

At most one email a day about Giles Richard Platford, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.